Factors predicting the quality of total mesorectal excision for rectal cancer

Annals of Surgery

Volumn 252, Issue 6, 2010, Pages 982-988

  Leonard, Daniel ^a   Penninckx, Freddy ^b   Fieuws, Steffen ^c   Jouret Mourin, Anne ^a   Sempoux, Christine ^a   Jehaes, Constant ^d   Van Eycken, Elizabeth ^e  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c KU LEUVEN   (Belgium)

^d Clinique Saint Joseph   (Belgium)

^e Belgian Cancer Registry   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURGERY; FEMALE; HEALTH CARE QUALITY; HUMAN; INTERMETHOD COMPARISON; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RECTUM ABDOMINOPERINEAL RESECTION; RECTUM CANCER; RECTUM RESECTION; RECTUM SURGERY; TOTAL MESORECTAL EXCISION; TREATMENT OUTCOME; TREATMENT RESPONSE; UNIVARIATE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; COLECTOMY; FEMALE; HUMANS; MALE; MIDDLE AGED; RECTAL NEOPLASMS; RECTUM;

EID: 78650107648     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181efc142     Document Type: Article

References (29)

1. Nagtegaal ID, Quirke P. What is the role for the circumferential margin in the modern treatment of rectal cancer J Clin Oncol. 2008;26:303-312.
2. Glynne-Jones R, Mawdsley S, Novell JR. The clinical significance of the circumferential resection margin following preoperative pelvic chemo-radio-therapy in rectal cancer: why we need a common language. Colorectal Dis. 2006;8:800-807. (Pubitemid 44541712)
3. Nagtegaal ID, Van De Velde CJ, Van Der Worp E, et al; Cooperative Clinical Investigators of the Dutch Colorectal Cancer Group. Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol. 2002;20:1729-1734. (Pubitemid 34273260)
4. Maslekar S, Sharma A, Macdonald A, et al. Mesorectal grades predict recurrences after curative resection for rectal cancer. Dis Colon Rectum. 2007;50:168-175. (Pubitemid 46227212)
5. Quirke P, Steele R, Monson J, et al. Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet. 2009;373:821-828.
6. Sebag-Montefiore D, Stephens RJ, Steele R, et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet. 2009;373:811-820.
7. Dahlberg M, Glimelius B, Pa hlman L. Changing strategy for rectal cancer is associated with improved outcome. Br J Surg. 1999;86:379-384. (Pubitemid 29145927)
8. Martling AL, Holm T, Rutqvist LE, et al; Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project. Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Lancet. 2000;8:356:93-96. (Pubitemid 30438509)
9. Kapiteijn E, Putter H, Van De Velde CJ. Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands. Br J Surg. 2002;89:1142-1149. (Pubitemid 34989221)
10. Wibe A, Møller B, Norstein J, et al. A national strategic change in treatment policy for rectal cancer- implementation of total mesorectal excision as routine treatment in Norway. A national audit. Dis Colon Rectum. 2002;45: 857-866. (Pubitemid 34761463)
11. Wibe A, Eriksen MT, Syse A, et al. Total mesorectal excision for rectal cancer- what can be achieved by a national audit Colorectal Dis. 2003;5: 471-477. (Pubitemid 37080656)
12. Wibe A, Carlsen E, Dahl O, et al. Nationwide quality assurance of rectal cancer treatment. Colorectal Dis. 2006;8:224-229. (Pubitemid 43379509)
13. Harling H, Bülow S, Kronborg O, et al. Survival of rectal cancer patients in Denmark during 1994-99. Colorectal Dis. 2004;6:153-157. (Pubitemid 38660633)
14. Pahlman L, Bohe M, Cedermark B, et al. The Swedish rectal cancer registry. Br J Surg. 2007;94:1285-1292. (Pubitemid 47584780)
15. Jessop J, Beagley C, Heald RJ. The Pelican Cancer Foundation and The English National MDT-TME Development Programme. Colorectal Dis. 2006;8(suppl 3):S1-S2.
16. Penninckx F, Van Eycken L, Michiels G, et al. Survival of rectal cancer patients in Belgium 1997-98 and the potential benefit of a national project. Acta Chir Belg. 2006;106:149-157. (Pubitemid 43709756)
17. Quirke P, Durdey P, Dixon MF, et al. Local recurrence of rectal adenocar-cinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet. 1986;2:996-999. (Pubitemid 16005611)
18. Quirke P, Dixon MF. The prediction of local recurrence in rectal adenocar-cinoma by histopathological examination. Int J Colorectal Dis. 1988;3:127-131.
19. den Dulk M, Krijnen P, Marijnen CA, et al. Improved overall survival for patients with rectal cancer since 1990: the effects of TME surgery and pre-operative radiotherapy. Eur J Cancer. 2008;44:1710-1716.
20. Nagtegaal ID, Van De Velde CJ, Marijnen CA, et al. Low rectal cancer: a call for a change of approach in abdominoperineal resection. J Clin Oncol. 2005;23:9257-9264.
21. Jeyarajah S, Sutton CD, Miller AS, et al. Factors that influence the adequacy of total mesorectal excision for rectal cancer. Colorectal Dis. 2007;9:808-815. (Pubitemid 47578027)
22. Baik SH, Kim NK, Lee KY, et al. Factors influencing pathologic results after total mesorectal excision for rectal cancer: analysis of consecutive 100 cases. Ann Surg Oncol. 2008;15:721-728.
23. Birbeck KF, Macklin CP, Tiffin NJ, et al. Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg. 2002;235:449-457. (Pubitemid 34258342)
24. Emslie J, Beart R, Mohiuddin M, et al. Use of rectal cancer position as a prognostic indicator. Am Surg. 1998;64:958-961. (Pubitemid 28462662)
25. Lee SH, Hernandez De Anda E, Finne CO, et al. The effect of circumferential tumor location in clinical outcomes of rectal cancer patients treated with total mesorectal excision. Dis Colon Rectum. 2005;48:2249-2257. (Pubitemid 43074445)
26. Marr R, Birbeck K, Garvican J, et al. The modern abdominoperineal excision: the next challenge after total mesorectal excision. Ann Surg. 2005;242:74-82. (Pubitemid 40917970)
27. Wibe A, Syse A, Andersen E, et al. Oncological outcomes after total mesorectal excision for cure for cancer of the lower rectum: anterior vs. abdominoperineal resection. Dis Colon Rectum. 2004;47:48-58. (Pubitemid 38040245)
28. Guillou PJ, Quirke P, Thorpe H, et al. Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet. 2005;365: 1718-1726. (Pubitemid 40719107)
29. Anderson C, Uman G, Pigazzi A. Oncologic outcomes of laparoscopic surgery for rectal cancer: a systematic review and meta-analysis of the literature. Eur J Surg Oncol. 2008;34:1135-1142.